Interaction of non-steroidal anti-inflammatory drugs, etoricoxib and parecoxib sodium, with human serum albumin studied by fluorescence spectroscopy

Drug Metabolism and Drug Interactions

Volumn 22, Issue 1, 2006, Pages 25-45

  Seedher, Neelam ^a   Bhatia, Sonu ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Etoricoxib; Fluorescence spectroscopy; Human serum albumin; Interaction; Mechanism; Parecoxib sodium

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; DANSYL CHLORIDE; ETORICOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; SERUM ALBUMIN;

ARTICLE; BINDING SITE; DRUG BINDING; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; HYDROPHOBICITY; PH MEASUREMENT; PHYSICAL CHEMISTRY; TEMPERATURE SENSITIVITY; THERMODYNAMICS;

EID: 33751226292     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2006.22.1.25     Document Type: Article

References (43)

1. Bertucci C, Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 2002; 9: 1463-1481.
2. Kragh-Hansen U, Chuang VTG, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002; 25: 695-704.
3. Levy RH, Moreland TA. Rationale for monitoring free drug levels. Clin Pharmacokinet 1984; 9 (Suppl 1): 1-9.
4. Rowland M. Plasma protein binding and therapeutic drug monitoring. Ther Drug Monit 1980; 2: 29-37.
5. Xie M, Xu X, Wang Y. Interaction between hesperetin and human serum albumin revealed by spectroscopic methods. Biochim Biophys Acta 2005; 1724: 215-224.
6. Pang YH, Yang LL, Shuang SM, Dong C, Thompson M. Interaction of human serum albumin with bendroflumethiazide studied by fluorescence spectroscopy. J Photochem Photobiol 2005; 80: 139-144.
7. Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol 1997; 24 (Suppl 49): 6-8.
8. Silas S, Clegg DO. Selective COX-2 inhibition. Bull Rheum Dis 1999; 40: 1-4.
9. Seedher N, Bhatia S. Mechanism of interaction of non-steriodal antiinflammatory drugs meloxicam and nimesulide with serum albumin. J Pharm Biomed Anal 2005; 39: 257-262.
10. Oberfelder RW, Lee JC. Measurement of ligand-protein interaction by electrophoretic and spectroscopic techniques. Meth Enzymol 1985; 117: 381-388.
11. Job P. Formation and stability of inorganic complexes in solution. Ann Chim 1928; 9: 113-203.
12. Rahman MH, Maruyama T, Okada T, Yamasaki K, Otagiri M. Study of interaction of carprofen and its enantiomers with human serum albumin-1. Biochem Pharmacol 1993; 46: 1721-1731.
13. Ward LD. Measurement of ligand binding to proteins by fluorescence spectroscopy. Meth Enzymol 1985; 117: 400-414.
14. Weber G, Young LB. Fragmentation of bovine serum albumin by pepsin. I. The origin of the acid expansion of the albumin molecule. J Biol Chem 1964; 239: 1415-1423.
15. Maruyama T, Otagiri M, Schulman SG. Binding characteristics of coumarin anticoagulants to human-aracid glycoprotein and human serum albumin. Int J Pharmaceut 1990; 59: 137-143.
16. Martin BK. Potential effect of the plasma proteins on drug distribution. Nature 1965; 207: 274-276.
17. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992; 358: 209-215.
18. Russeva V, Mihailova D. Binding of phenylbutazone to human serum albumin. Arzneim-Forsch/Drug Res 1999; 49: 255-258.
19. Trivedi VD, Vorum H, Honore B, Qasim MA. Molecular basis of indomethacin-human serum albumin interaction. J Pharm Pharmacol 1999; 51: 591-600.
20. He W, Li Y, Xue C, Hu Z, Chen X, Sheng F. Effect of Chinese medicine alpinetin on the structure of human serum albumin. Bioorg Med Chem 2005; 13: 1837-1845.
21. Aki H, Yamamoto M. Thermodynamics of the binding of phenothiazines to human plasma, human serum albumin and alpha-acid glycoprotein. A calorimetric study. J Pharm Pharmacol 1989; 41: 674-679.
22. Seedher N, Singh B, Singh P. Mode of interaction of metronidazole with bovine serum albumin. Indian J Pharm Sci 1999; 61: 143-148.
23. Ross PD, Subramanian S. Thermodynamics of protein association reactions. Forces contributing to stability. Biochemistry 1981; 20: 3096-3102.
24. Fernandez GM, Lumbreras JM, Ordonez D. A thermodynamic approach to the binding mechanisms of cefotaxime to serum albumins. J Pharm Sci 1993; 82: 948-951.
25. Li Y, He W, Liu J, Sheng F, Hu Z, Chen X. Binding of the bioactive component jatrorrhizine to human serum albumin. Biochim Biophys Acta 2005; 1722: 15-21.
26. Barbosa S, Taboada P, Mosquera V. Analysis of the interactions between human serum albumin/amphiphilic penicillin in different aqueous media: an isothermal titration calorimetry and dynamic light scattering study. Chem Phys 2005; 310: 51-58.
27. Jun HW, Ruenitz PC. Interaction of tricyclic antipsychotic and antidepressant drugs with 1-anilino-8-naphthalenesulfonic acid. J Pharm Sci 1978; 67: 861-863.
28. Seedher N. In vitro study of the mechanism of interaction of trifluoperazine dihydrochloride with bovine serum albumin. Indian J Pharm Sci 1999; 62: 16-20.
29. Sudlow G, Birkett D, Wade D. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975; 11: 824-832.
30. Sudlow G, Birkett D, Wade D. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 1976; 12: 1052-1061.
31. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng 1999; 12: 439-446.
32. Chuang VT, Kuniyasu A, Nakayama H, Matsushita Y, Hirono S, Otagiri M. Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an aryl propionic acid NSAID containing a benzophenone moiety. Biochim Biophys Acta 1999; 1434: 18-30.
33. Wanwimolruk S, Birkett DJ, Brooks PM. Structural requirements for drug binding to site II on human serum albumin. Mol Pharmacol 1983; 24: 458-463.
34. Otagiri M, Masuda K, Imai T, Imamura Y, Yamasaki M. Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques. Biochem Pharmacol 1989; 38: 1-7.
35. Watanabe H, Tanase S, Nakajou K, Maruyama T, Kragh-Hansen U, Otagiri M. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J 2000; 349: 813-819.
36. Eftink MR, Ghiron CA. Fluorescence quenching studies with proteins. Anal Biochem 1981; 114: 199-227.
37. Eftink MR, Ghiron CA. Fluorescence quenching of indole and model micelle systems. J Phys Chem 1976; 80: 486-493.
38. Lehrer SS. Solute perturbation of protein fluorescence. The quenching of tryptophan fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 1971; 10: 3254-3256.
39. Gonzalez-Jimenez J, Frutos G, Cayre I. Fluorescence quenching of human serum albumin by xanthines. Biochem Pharmacol 1992; 44: 824-826.
40. Lakowicz JR. Principles of Fluorescence Spectroscopy. New York: Plenum Press, 1983; 257-295.
41. Campbell ID, Dwek RA. Biological Spectroscopy. London: The Benjamin/Cummings Publishing Company Inc., 1984; 108-109.
42. Cui FL, Fan J, Li W, Fan YC, Hu ZD. Fluorescence spectroscopic studies on 5-aminosalicylic acid and zinc 5-aminosalicylate - interaction with human serum albumin. J Pharm Biomed Anal 2004; 34: 189-197.
43. Wilting J, Van der Giesen WF, Janssen LHM. The effect of chloride on the binding of warfarin to albumin as a function of pH. Biochem Pharmacol 1981; 30: 1025-1031.